肝动脉输液化疗在肝细胞癌的当前疗效

Douglas Dias E Silva1, Mitesh Borad2, Pedro Luiz Serrano Uson Junior3

  • 1Department of Oncology, Hospital Israelita Albert Einstein, São Paulo 05652900, Sao Paulo, Brazil.

概括

肝动脉输液化疗 (HAIC) 对于晚期肝细胞癌 (HCC) 是有前途的. 与系统疗法结合HAIC,与单独使用HAIC相比,提供更好的生存结果.